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Abstract
Angiomyolipoma with epithelial cysts (AMLEC) is a recently described distinct cystic variant of
angiomyolipoma (AML). To date 15 cases of AMLEC have been reported in 2 case series. We
report the 16th case in a 39-year-old female. Her left kidney tumor was discovered incidentally.
Partial nephrectomy was performed. Histologically, the tumor was composed of three
components: 1) epithelial cysts lined by cuboidal to hobnail cells; 2) compact subepithelial
mullerian-like AML stroma with admixed chronic inflammation; and 3) muscle-predominant AML
with dysmorphic blood vessels exterior to the subepithelial stroma. Immunohistochemically, the
subepithelial stroma stained most intensely with HMB-45 and Melan-A, whilst the muscle-
predominant AML areas stained most intensely with smooth muscle actin and desmin. Estrogen
receptor (ER), progesterone receptor (PR), and CD10 stained most intensely in the subepithelial
stroma. The cyst lining was positive for pancytokeratin, but negative for HMB-45, Melan-A, ER, PR,
and CD10. The patient is alive with no evidence of disease, 12 months postoperatively, and yearly
follow-up CT scans are planned.
Background
Angiomyolipomas (AMLs) are well-characterized tripha-
sic tumors composed of varying amounts of vascular
(thick-walled dysplastic or dysmorphic blood vessels),
smooth muscle (spindled or epithelioid with clear cyto-
plasm) and mature adipose elements [1]. AML usually
occurs in the kidney, but can occasionally involve the liver
and retroperitoneum. AML comprise 2.0–6.4% of all
renal tumors, however they represent one of the most
common benign renal lesions [1]. AML can occur as an
isolated renal lesion or as part of the tuberous sclerosis
complex (TSC). Approximately 50% of patients with TSC
develop AML, which tend to be bilateral and multifocal
[2]. The triphasic nature of AML has led many in the past
to consider these lesions as hamartomatous. However,
recent detection of clonal genomic alterations [3-5] and
rare case reports of malignancy in AMLs [1,6-8] favor their
classification as neoplastic lesions. AMLs share morpho-
logic and immunohistological features with perivascular
epithelioid cell (PEC), and are considered to be among
the growing family of tumors derived from these distinc-
tive cells, also referred to as PEComas, and that includes
clear cell ("sugar") tumors of the lung and pancreas, and
lymphangioleiomyomatosis [9,10]. Although the diagno-
sis of AML is usually straightforward, some cases showing
predominance of any one of the AML components may
mimic a number of lesions and lead to an erroneous diag-
nosis of malignancy, including liposarcoma (fat-predom-
inant AML), leiomyoma (muscle-predominant AML),
renal cell carcinoma (epithelioid AML), and vascular mal-
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[11]. The evolution of AML is classically benign, but
malignant transformation has been rarely reported in 12
cases to date [1,6-8].
AMLs are typically solid lesions both radiologically and
grossly [1], without cystic or epithelial components.
Although entrapped non-cystic renal tubules have been
described in AML, presentation as a cystic mass has been
reported recently in only 15 cases in two case series
[11,12]. This distinctive benign renal neoplasm has
recently been recognized and termed angiomyolipoma
with epithelial cysts (AMLEC) by Fine and colleagues [11]
or cystic angiomyolipoma by Davis and colleagues [12].
These descriptive names for this entity are currently
favored until its pathogenesis and relationships to other
renal neoplasms are better understood. Therefore, AMLEC
or cystic AML has to be considered in the differential diag-
nosis of adult cystic renal neoplasms, which includes
cystic renal cell carcinomas, cystic nephroma (CN), and
mixed epithelial and stromal tumor (MEST). The most
distinctive immunohistochemical feature of AMLEC or
cystic AML, absent in the above three tumors mentioned
earlier is immunoreactivity with melanocytic markers
(HMB45 and Melan-A) [11,12]. We report herein one
more case of AMLEC or cystic AML in a 39-year-old
female.
Case presentation
A 39-year-old woman had a left kidney tumor incidentally
discovered during CT scan as part of a diagnostic workup
for colonic diverticulosis. She had no personal or family
history of TSC, lymphangioleiomyomatosis, renal cyst,
renal malignancy, or estrogen hormonal therapy. The CT
scan revealed a 2.5-cm complex cystic mass in the upper
pole of the left kidney with a 1-cm enhancing nodule in
its wall, radiologically worrisome for cystic renal cell car-
cinoma. In view of this concern of malignancy, the patient
elected to undergo laparoscopic left partial nephrectomy
for definitive surgical treatment. The entire tumor was sur-
gically resected with an excellent margin of 5-mm of nor-
mal parenchyma surrounding the entire cyst wall, and the
tumor was confined to the kidney.
Grossly, the tumor was well demarcated and partially
cystic, with the largest cyst measuring up to 1.1-cm. Sec-
tioning of the tumor revealed part of the cyst wall con-
tained a single 1-cm mural nodule with homogenous tan
cut surface. The entire tumor was submitted for histologi-
cal examination and revealed three components. The first
component was cystic or multicystic spaces lined by epi-
thelium, that ranged from flat to cuboidal to columnar.
Whilst the cuboidal to columnar cells had unremarkable
clear cytoplasm, the flat cells had abundant eosinophilic
cytoplasm with nuclei that often protruded into the
lumen, resulting in a hobnailed appearance (Figure 1A).
The second component was a subepithelial "cambium-
like" condensation of small stromal cells with indistinct
cytoplasm immediately subjacent to the cyst epithelium.
This subepithelial stroma showed prominent capillary
vasculature (reminiscent of endometrial or mullerian-like
stroma) and prominent lymphoplasmacytic infiltrate
(Figure 1B). The third component was a thick exterior wall
of plump smooth muscle cells with focally clear cyto-
plasm arranged in poorly formed fascicles, often appear-
ing to emanate from irregular and tortuous blood vessels
(Figure 1C). The third component was exterior to the sub-
epithelial stroma and was typical of myomatous or mus-
cle-predominant predominant AML. Additionally, non-
cystic native renal tubules were observed entrapped
within this exterior muscular wall (Figure 1D).
Immunohistochemically, HMB45 (Figure 2A) and Melan-
A labeling was patchy in the exterior muscle-predominant
AML component, but were most intense and concentrated
in the compact subepithelial cellular stroma. Conversely,
smooth muscle actin (Figure 2B) and desmin labeling was
most intense and concentrated in the exterior muscle-pre-
dominant AML component, but were patchy in the com-
pact subepithelial cellular stroma. Similarly, the compact
subepithelial cellular stroma showed strong and diffuse
nuclear labeling for estrogen receptor (ER) (Figure 2C)
and progesterone receptor (PR) (Figure 2D), along with
Histologic (H&E) findings of three components of AMLECFigure 1
Histologic (H&E) findings of three components of AMLEC. 
(A) Epithelial cysts lined by cuboidal to hobnail cells. Original 
magnification X400. (B) Compact subepithelial "cambium-
like" layer of cellular, mullerian-like AML stroma with promi-
nent admixed chronic inflammation. Original magnification 
X200. (C) Muscle-predominant AML with associated dys-
morphic blood vessels. Original magnification X200. (D) 
Non-cystic native tubules entrapped in muscle-predominant 
AML. Original magnification X200.Page 2 of 5
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3A), but labeling for ER (Figure 2C), PR (Figure 2D), and
CD10 (Figure 3A) were patchy in the exterior muscle-pre-
dominant AML component. However, vimentin (Figure
3B) showed strong and diffuse cytoplasmic labeling of all
3 components equally. The cyst lining was positive for
epithelial markers (pancytokeratin [Figure 3C], AE1-AE3,
and CK7), but negative for melanocytic (HMB-45 [Figure
2A] and Melan-A), muscular (smooth muscle actin [Fig-
ure 2B] and desmin), and hormonal (ER [Figure 2C] and
PR [Figure 2D]) markers. The tumor showed low prolifer-
ative index with Ki67 labeling less than 1% of neoplastic
cells (Figure 3D). Additionally, RCC marker antigen,
inhibin, WT-1, c-kit (CD117), S-100 protein, and CK20
did not label any of the 3 components of the tumor (not
shown). Except for patchy labeling of blood vessels, CD34
(endothelial markers) did not label any of the 3 compo-
nents of the tumor (not shown). The patient herein pre-
sented is alive with no evidence of recurrence or
metastatic disease, 12 months postoperatively, and fol-
low-up with interval abdominal imaging studies is
planned.
Discussion
The renal tumor herein presented was histologically and
immunophenotypically diagnostic of muscle-predomi-
nant AML containing prominent and grossly evident epi-
thelial cysts. This phenotype is distinctly unusual, as AMLs
are typically solid [1], and reminiscent of the recently
described distinct cystic variant of AML that has been
seperately designated as cystic AML or AMLEC [11,12]. It
is well known that AMLs occur both in association with
TSC and sporadically [1]. Bilateral or multiple AMLs have
been considered presumptive evidence of, or diagnostic
of, TSC [2]. The case herein presented had no personal or
family history of TSC. From the 15 previously reported
[11,12] and our case of AMLEC, only 1 out of these 16
cases of AMLEC was associated with TSC, suggesting that
this rare variant of AML may not be related to TSC. Addi-
tionally, the female/male ratio is 10/6 for these 16 cases of
AMLEC, indicating a slight female predominance for
AMLEC. Therefore, unlike MEST which is considered
estrogen hormone dependent because of its almost exclu-
sive occurrence in females, AMLEC may be estrogen hor-
mone independent. AMLs have been considered benign
lesions and those found in the kidney are generally man-
aged conservatively. Partial nephrectomy or angiographic
embolization has been recommended for symptomatic
lesions and lesions greater than 4-cm, and most asympto-
matic lesions are followed with interval abdominal imag-
ing [13]. However, 12 cases of metastatic AML have been
reported [1,6-8]. Though the asymptomatic cystic renal
tumor in the case herein presented was less than 4-cm in
greatest dimension, definitive surgical treatment was pur-
sued because of the presence of a radiologically enhancing
Immunohistochemical (IHC) findings of AMLECFigure 2
Immunohistochemical (IHC) findings of AMLEC. (A) Com-
pact subepithelial stroma showed most intense HMB45 stain-
ing. Original magnification X200. (B) Muscle-predominant 
AML showed most intense smooth muscle actin staining. 
Original magnification X200. (C) Compact subepithelial 
stroma showed diffuse strong ER staining. Original magnifica-
tion X200. (D) Compact subepithelial stroma showed diffuse 
strong PR staining. Original magnification X200.
Immunohistochemical (IHC) findings of AMLECFigure 3
Immunohistochemical (IHC) findings of AMLEC. (A) Com-
pact subepithelial stroma showed diffuse strong CD10 stain-
ing. Original magnification X200. (B) Diffuse strong vimentin 
staining in all 3 components equally. Original magnification 
X200. (C) Epithelium lining the cystic spaces showed strong 
intense pancytokeratin staining. Original magnification X200. 
(D) Ki67 staining showed low proliferative index of less than 
1% of neoplastic cells. Original magnification X200.Page 3 of 5
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nancy.
AMLEC are readily distinct from most adult cystic renal
lesions. The chief differential diagnostic consideration for
AMLEC or cystic AML is mixed epithelial and stromal
tumor (MEST), previously classified as cystic hamartomas
of the renal pelvis, adult mesoblastic nephroma, or renal
pelvic or cortical hamartomas [11,12]. Immunohisto-
chemically, the stroma of both AMLEC and MEST labels
for smooth muscle actin, desmin, ER, and PR [11,12].
However, the most distinctive immunohistochemical fea-
ture of AMLEC or cystic AML, absent in all the differential
diagnostic considerations mentioned above, is immunos-
taining with melanocytic markers (HMB45 and Melan-A)
[11,12], as noted in our case. This study further expands
on the immunophenotype of this new histologic entity by
reporting for the first time that AMLEC shows absence of
immunoreactivity for WT-1, c-kit and CK20. The other
important benign differential diagnostic consideration for
AMLEC or cystic AML is cystic nephroma (CN). The main
malignant differential diagnostic consideration for
AMLEC or cystic AML is multilocular cystic renal cell car-
cinoma. Based on the results of immunohistochemical
staining in the case herein presented, cystic and sarcoma-
tous renal cell carcinoma (HMB45 negative), cystic neph-
roma (HMB45 negative), mixed epithelial and stromal
tumor (HMB45 negative), leiomyosarcoma (HMB45 neg-
ative), and melanoma (HMB45 positive, S-100 protein
positive) were excluded as differential diagnoses. The
presence of HMB45 in PEC of AML has been widely recog-
nized as a specific finding, however, that of c-kit (CD117)
has not been as common [4,6,9]. According to recent
reports, c-kit is also expressed in renal oncocytoma (71%),
chromophobic renal cell carcinoma (85%) and even in
PEC in classic AML [14,15]. The case we describe was not
immunoreactive for c-kit.
The histogenesis of AMLEC or cystic AML is unclear. How-
ever, the histogenesis of the mullerian-like stroma in
AMLEC has been postulated to be due to the embryologi-
cal proximity between the urinary and genital systems
[11]. These two systems share common origin from the
urogenital ridge, and it has been postulated that distur-
bances during a critical period in development may lead
to crossover of epithelium or mesenchymal elements
between the two systems, predisposing to neoplasms that
combine these features [11]. The strong HMB-45 positiv-
ity of the "cambium-like" layer of compact subepithelial
cells in AMLEC supports the concept that they are a vari-
ant of AML, although their morphology is distinctly differ-
ent from the exterior muscle-predominant AML wall. The
mullerian histomorphology and peculiar immunohisto-
chemical profile (HMB45+, Melan-A+, ER+, PR+, and
CD10+) of the compact subepithelial cells suggests both
mullerian and melanocytic differentiation of PECs in
AMLEC, a rare variant of AML [11]. This observation of
dual differentiation is not unprecedented in AML, since
the smooth muscle cells of AMLs are known to have both
melanocytic and muscular features [1,4,6,9]. The minimal
immunoreactivity for muscle markers in this subepithelial
zone suggests that these cells have lost some of their mus-
cular phenotype while developing a mullerian phenotype.
Apart from the fact that the presence of epithelium is
extremely uncommon in AML and has been reported pre-
viously in only 15 cases [11,12], the nature of the epithe-
lium within AMLEC is also controversial. Davis and
colleagues [12] favored the view that the epithelial com-
ponent of AMLEC represented true epithelial differentia-
tion by the AML, whilst Fine and colleagues [11] favored
the view that it mainly represented dilated entrapped
native renal collecting duct epithelium. Both views are
plausible.
Conclusion
AMLEC should be routinely included in the differential
diagnostic considerations for adult cystic renal neo-
plasms, which includes cystic renal cell carcinomas, cystic
nephroma (CN), and mixed epithelial and stromal tumor
(MEST). Although, AMLEC may be confused with MEST,
the most distinctive feature is the fact that AMLEC is
immunoreactive to melanocytic markers (HMB45 and
Melan-A).
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